StockNews.AI
QDEL
StockNews.AI
26 days

Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast

1. QuidelOrtho discusses urgent diagnostic testing in emergency care settings. 2. Escalating complexities in substance use detection are highlighted. 3. Challenges from potent synthetic drugs are increasing for healthcare providers. 4. Narcan's limitations require continuous monitoring and comprehensive toxicology screening.

6m saved
Insight
Article

FAQ

Why Bullish?

The focus on enhancing diagnostic solutions and increasing sales in emergency settings may boost QDEL's market position, as evidenced in past growth during healthcare crises.

How important is it?

The article highlights significant industry trends that align with QDEL's strategic focus on diagnostics, possibly leading to increased investor interest.

Why Long Term?

As the demand for diagnostic tools in emergency care continues to rise, QDEL is likely to benefit from sustained growth opportunities.

Related Companies

ADPTIDXXABTRMD
Episode 49 of QuidelOrtho Science Bytes explores substance use trends, the limits of Narcan, and the evolving challenges facing emergency departments, /PRNewswire/ -- In emergency care settings, every second counts. Early drug detection not only improves clinical decision-making, it can be the difference between life and death. But with the rise of counterfeit medications and drug combinations that are more potent and less predictable, emergency departments must adapt faster than ever. Vonda McAllister, Director of Global Product Management, QuidelOrtho. QuidelOrtho Science Bytes Episode 49 "How Urgent Diagnostic Testing Can Help Prevent Drug Overdose Deaths," addresses the escalating complexities of substance use detection and care in emergency departments across the country. The episode features Vonda McAllister, Director of Global Product Management at QuidelOrtho, whose deep experience in diagnostics and toxicology provides critical perspective on the clinical and societal impacts of today's most dangerous drug trends. Subscribe to QuidelOrtho Science Bytes Episode Highlights: How rapid diagnostic testing is saving lives Understanding the unpredictable nature of polydrug overdoses The increasing prevalence of potent synthetic drugs like fentanyl, xylazine ("tranq"), and nitazines The limitations of Narcan (naloxone) and the rising need for repeated doses due to powerful opioid analogs California's "Tyler's Law," which mandates fentanyl testing in suspected overdose cases Key Quotes:Vonda McCallister, Director of Global Product Management, QuidelOrtho"As overdose presentations become more complex, continuous monitoring, comprehensive toxicology screening and clinical vigilance are essential tools in the fight against this crisis."About QuidelOrtho Science BytesScience Bytes is a monthly podcast that delivers diagnostic insights and innovation updates from QuidelOrtho, helping healthcare providers stay informed and prepared. Episode 49 is now available on all major podcast platforms.For more information and to listen to the full episode, visit www.quidelortho.com/sciencebytes.About QuidelOrtho CorporationQuidelOrtho Corporation (Nasdaq: QDEL) is a global provider of innovative diagnostic testing solutions. From infectious diseases to cardiac biomarkers to women's health, QuidelOrtho transforms the power of diagnostics into a healthier future through science, innovation, and accessibility. Learn more at www.quidelortho.com.Source: QuidelOrtho Corporation Investor Contact: Juliet Cunningham Vice President, Investor Relations [email protected] Media Contact: D. Nikki Wheeler Senior Director, Corporate Communications [email protected] SOURCE QuidelOrtho Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News